Sally Massey - May 15, 2023 Form 4 Insider Report for COLGATE PALMOLIVE CO (CL)

Role
Chief Human Resources Officer
Signature
/s/ Kristine Hutchinson, Attorney-in-Fact
Stock symbol
CL
Transactions as of
May 15, 2023
Transactions value $
-$124,779
Form type
4
Date filed
5/17/2023, 04:07 PM
Previous filing
May 5, 2023
Next filing
Sep 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CL Common Stock Options Exercise $1.07M +14.6K +169.4% $73.00 23.2K May 15, 2023 Direct F1
transaction CL Common Stock Sale -$1.19M -14.6K -62.88% $81.55 8.62K May 15, 2023 Direct F2, F3
holding CL Common Stock 7.46K May 15, 2023 By Issuer's 401(k) Plan Trustee

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CL Stock Option (Right to Buy) Options Exercise $0 -14.6K -100% $0.00* 0 May 15, 2023 Common Stock 14.6K $73.00 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Exercise of stock options awarded under the issuer's incentive compensation plan. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2022.
F2 Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2022.
F3 Weighted average price, as these shares were sold in multiple transactions at prices ranging from $81.13 to $82.081, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Option became exercisable in one-third increments beginning on the first anniversary of the September 25, 2017 grant date.